Erasca ERAS
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$21.06M (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 36.2% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 8.82% to 10.62% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Capital Research | Mutual Fund | 2026/Q3 | +8,656,799 | 2.7% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +6,060,267 | 2.4% |
| Assenagon Asset Management S.A. | Mutual Fund | 2026/Q3 | +3,315,456 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,581,932 | 6.8% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +2,503,597 | 4.0% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +1,800,000 | 3.8% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,637,088 | 4.0% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +1,137,925 | 0.9% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +4,383,361 | 7.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +2,884,471 | 3.5% |
| Jennison Associates LLC | Mutual Fund | 2026/Q3 | +2,788,412 | 0.8% |
| Soleus Capital Management, L.P. | Hedge Fund | 2026/Q3 | +2,700,000 | 0.8% |
| Samlyn Capital, LLC | Hedge Fund | 2026/Q3 | +2,256,986 | 0.6% |
| Norges Bank Investment Management | Sovereign Wealth Fund | 2026/Q3 | +2,114,390 | 0.6% |
| RTW Investments, LP | Hedge Fund | 2026/Q3 | +1,789,579 | 5.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Aug 2026 | Charles Fuchs | President of Research & Development | Other Derivative Acquisition | +1,300,000 | $18.12 | 1,300,000 |
| 25 Jun 2026 | Jean I. Liu | Independent Director | Other Derivative Acquisition | +29,888 | $16.01 | 29,888 |
| 25 Jun 2026 | Alexander Casdin | Independent Director | Other Derivative Acquisition | +29,888 | $16.01 | 29,888 |
| 25 Jun 2026 | Pratik Multani | Independent Director | Other Derivative Acquisition | +29,888 | $16.01 | 29,888 |
| 25 Jun 2026 | James Bristol | Lead Independent Director | Other Derivative Acquisition | +29,888 | $16.01 | 29,888 |
| 25 Jun 2026 | Julie Hambleton | Independent Director | Other Derivative Acquisition | +29,888 | $16.01 | 29,888 |
| 25 Jun 2026 | Valerie Harding-Start | Independent Director | Other Derivative Acquisition | +29,888 | $16.01 | 29,888 |
| 31 Mar 2026 | Ebun Garner | Chief Legal Officer | Derivative Exercise and Sale | -80,000 | $16.40 | 25,076 |
| 3 Mar 2026 | Shannon Morris | Chief Medical Officer | Derivative Exercise and Sale | -20,000 | $15.04 | – |
| 28 Jan 2026 | Michael Varney | Chairman of Research & Development, Scientific Advisory Board Member and Director | Other Derivative Acquisition | +96,000 | $10.31 | 96,000 |
| 28 Jan 2026 | Jonathan Lim | Chairperson & CEO | Other Derivative Acquisition | +2,000,000 | $10.31 | 2,000,000 |
| 28 Jan 2026 | Ebun Garner | Chief Legal Officer | Other Derivative Acquisition | +560,000 | $10.31 | 560,000 |
| 28 Jan 2026 | Shannon Morris | Chief Medical Officer | Other Derivative Acquisition | +625,000 | $10.31 | 625,000 |
| 28 Jan 2026 | David Chacko | CFO & Chief Business Officer | Other Derivative Acquisition | +640,000 | $10.31 | 640,000 |
| 6 Jan 2026 | Ebun Garner | Chief Legal Officer | Derivative Exercise and Sale | -120,000 | $5.59 | 25,076 |
| 31 Dec 2025 | Jean I. Liu | Independent Director | Other Derivative Acquisition | +20,617 | $3.72 | 20,617 |
| 31 Dec 2025 | Alexander Casdin | Independent Director | Other Derivative Acquisition | +23,872 | $3.72 | 23,872 |
| 31 Dec 2025 | Pratik Multani | Independent Director | Other Derivative Acquisition | +19,532 | $3.72 | 19,532 |
| 31 Dec 2025 | James Bristol | Lead Independent Director | Other Derivative Acquisition | +37,762 | $3.72 | 37,762 |
| 31 Dec 2025 | Valerie Harding-Start | Independent Director | Other Derivative Acquisition | +24,306 | $3.72 | 24,306 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 37,156,627 | 10.6% | 8.9 |
| 15 Oct 2026 | 36,963,404 | 10.6% | 6.4 |
| 30 Sep 2026 | 35,338,107 | 10.1% | 6.9 |
| 15 Sep 2026 | 33,036,139 | 9.4% | 7.7 |
| 31 Aug 2026 | 31,238,099 | 8.9% | 9.4 |
| 14 Aug 2026 | 30,847,289 | 8.8% | 10.0 |
No comments yet — be the first to weigh in on ERAS.
Sign in to join the discussion.